Summary:The kinetics of the regional cerebral uptake of ["C] 3-0-methyl-o-glucose (["C1MeG), a competitive in hibitor of o-glucose transport, have been studied in normal human subjects and patients with cerebral tu mours using positron emission tomography (PET), Con comitant measurement of regional cerebral blood volume and blood flow enabled corrections for the contribution of intravascular tracer signal in PET scans to be carried out and regional unidirectional cerebral ["C1MeG extrac tions to be determined, A three-compartment model con taining an arterial plasma and two cerebral compartments was required to produce satisfactory fits to experimental regional cerebral [ l lCJMeG uptake data. Under fasting, resting conditions, normal controls had mean unidirec tional whole-brain, cortical, and white matter ["C1MeG extractions of 14, 13, and 17%, respectively. Mean values of k, and k2, first-order rate constants describing forward and back transport, respectively, of tracer into the first cerebral compartment, were similar for ["C1 MeG and ['8F] 2-fluoro-2-deoxy-o-glucose ( , 8FDG), a second comStudies on intact dog and rat brain, and also on isolated cerebral rat brain capillaries, have shown that D-glucose transport across the blood-brain barrier (BBB) is a passive facilitated process (Crone, 1965; Betz et aI., 1973 Betz et aI., , 1979 Pard ridge and Oldendorf, 1975). 3-0-Methyl-D-glucose (MeG) and 2-deoxY-D-glucose (2-DG) have both been shown to